SYNGENE IN EQUITY
loading…—
Day range—
52-week range—
Market cap—
P/E · TTM—
As of—
| CUSTOMER | BASIS | EST ₹CR | RANGE | % REV | BUCKET | PERIOD | METHOD | CONF |
|---|---|---|---|---|---|---|---|---|
| Business | REV SHARE | 3,365 | 3,365–3,365 | 90.0% | — | FY26 | DISC | 90% |
| “Details of business activities (accounting for 90% of the turnover): S. No. Description of Main Activity Description of Business Activity % of Turnover of the …” AR · +2 DOC | ||||||||
| BRITANNIABritannia Industries Ltd. | UNSTATED | 3,365 | 2,199–3,365 | 90.0% | — | FY26 | EST | 75% |
| “She served as Chief Executive Officer & MD of Britannia Industries Ltd., from 2005 to 2014.” AR · +1 DOC | ||||||||
| TRENTTrent Ltd. | UNSTATED | 2,888 | 1,887–2,888 | 77.2% | — | FY25 | EST | 75% |
| “She serves on the Boards of Syngene International Limited, Narayana Hrudayalaya Limited, Trent Limited and PureTech Health Plc.” AR DOC | ||||||||
| BAJAJ-AUTOBajaj Auto Ltd. | UNSTATED | 1,367 | 893–1,367 | 36.6% | — | FY26 | EST | 75% |
| “At present, she is a Non-Executive Director on the global boards of SATS Ltd and Cognizant Technology Solutions, and in India, serves on the board of Bajaj Aut…” AR · +1 DOC | ||||||||
| Shell) | UNSTATED | — | — | — | — | FY26 | EST | 75% |
| “At present, she is a Non-Executive Director on the global boards of SATS Ltd and Cognizant Technology Solutions and in India, she serves on the board of Bajaj …” AR DOC | ||||||||
| Dr. Reddy's And Nestle Health Science | UNSTATED | — | — | — | — | FY26 | EST | 75% |
| “He also serves as a Non- Executive Director on the Board of Dr. Reddy’s and Nestle Health Science Limited.” AR DOC | ||||||||
| United States | UNSTATED | — | — | — | — | FY26 | EST | 75% |
| “Revenue from operations: India 1,637 1,458 United States of America 20,881 21,178 Europe 9,762 7,718 Rest of the World 1,453 1,676 Total 33,733 32,031Statutory…” AR · +2 DOC | ||||||||
| United States | UNSTATED | — | — | — | R&D | FY26 | EST | 75% |
| “Set out below is the disaggregation of revenue: Year ended 31 March 2025 Year ended 31 March 2024 Revenues from Contract research and manufacturing services in…” AR · +1 DOC | ||||||||
| BIOCONBiocon Ltd. | UNSTATED | — | — | — | — | FY26 | EST | 75% |
| “The Company invested around USD 50 Mn in Syngene USA Inc. (SUSA), a wholly owned subsidiary of the Company to finance the cost of acquisition of biologics faci…” AR DOC | ||||||||
| NHNarayana Hrudayalaya Ltd. | UNSTATED | — | — | — | — | FY25 | EST | 75% |
| “She serves on the Boards of Syngene International Limited, Narayana Hrudayalaya Limited, Trent Limited and PureTech Health Plc.” AR DOC | ||||||||
| ATHERENERGAther Energy Ltd. | UNSTATED | — | — | — | — | FY25 | EST | 75% |
| “Previously, Deepak served as the Chief Financial Officer (CFO) at Ather Energy, where he was instrumental in driving the company’s substantial revenue growth o…” AR DOC | ||||||||
| Others | UNSTATED | — | — | — | — | FY26 | EST | 70% |
| “Other liabilities 31 March 2025 31 March 2024 (a) Non-current Deferred revenues 2,188 2,438 2,188 2,438 (b) Current Advances from customers 6,049 4,986 Deferre…” AR · +1 DOC | ||||||||
| Business | UNSTATED | — | — | — | R&D | FY26 | EST | 70% |
| “We work with over 400 customers across industry segments *All product names, logos, brands, trademarks and registered trademarks are the property of their resp…” AR · +1 DOC | ||||||||
| Australia | UNSTATED | — | — | — | — | FY26 | EST | 70% |
| “Her visionary journey has earned her several coveted titles and awards, both national and international, including India’s top civilian awards, Padma Shri (198…” AR · +1 DOC | ||||||||
| China. | UNSTATED | — | — | — | — | FY26 | EST | 70% |
| “A key dynamic for the year was the marked increase in customer RFP’s as they explored alternative options to rebalance their CRDMO business exposure away from …” AR · +1 DOC | ||||||||
| BIOCONBiocon Ltd. | UNSTATED | — | — | — | R&D | FY26 | EST | 70% |
| “Over more than 25 years, this partnership has evolved into a deep and highly integrated engagement, with the Biocon Bristol Myers Squibb Research & Development…” AR · +1 DOC | ||||||||
| Others | UNSTATED | — | — | — | R&D | FY26 | EST | 70% |
| “We work with over 400 customers across industry segments *All product names, logos, brands, trademarks and registered trademarks are the property of their resp…” AR · +1 DOC | ||||||||
| Authority. | UNSTATED | — | — | — | — | FY26 | EST | 70% |
| “85 Client and regulatory audits completed during FY26Statutory Reports Financial StatementsBusiness Review Annual Report 2026 | 49 Area Agency/Standard Site/Sc…” AR DOC | ||||||||
| FY27 | UNSTATED | — | — | — | — | FY27 | EST | 70% |
| “The year witnessed: Deployment of Power Business Intelligence (BI) dashboards providing real-time EHSS performance visibility Standardization of global EHS…” AR · +1 DOC | ||||||||
| Securities and Exchange Board of India | UNSTATED | — | — | — | — | FY26 | EST | 70% |
| “f. The Securities and Exchange Board of India (Registrars to an Issue and Share Transfer Agents) Regulations, 1993 regarding the Companies Act and dealing with…” AR · +1 DOC | ||||||||
| Karnataka | UNSTATED | — | — | — | CAPEX | FY26 | EST | 70% |
| “Fax: +91 80 4682 3999 Registrar and Share Transfer Agents KFin Technologies Limited (Unit: Syngene International Limited) Plot No. 31 & 32, Selenium Tower - B,…” AR · +1 DOC | ||||||||
| KFINTECHKfin Technologies Ltd. | UNSTATED | — | — | — | — | FY26 | EST | 70% |
| “Registrar and Share Transfer Agents The members of the Company may address all their communication relating to transfer, transmission, refund order, dividend, …” AR · +1 DOC | ||||||||
| Financial Year | UNSTATED | — | — | — | — | FY26 | EST | 70% |
| “Complaints/Grievances on any of the principles (Principle 1 to 9) under the National Guidelines on Responsible Business Conduct: Stakeholder group from whom co…” AR · +1 DOC | ||||||||
| Financial Year | UNSTATED | — | — | — | R&D | FY26 | EST | 70% |
| “FY25 Current Financial Year FY24 Previous Financial Year Details of improvements in environmental and social impacts R&D@ Nil Nil NA Capex Nil Nil NA @Syngene …” AR · +1 DOC | ||||||||
| Joint Commissioner | UNSTATED | — | — | — | SG&A | FY26 | EST | 70% |
| “(b) According to the information and explanations given to us and on the basis of our examination of the records of the Company, statutory dues relating to Goo…” AR DOC | ||||||||
| KFINTECHKfin Technologies Ltd. | UNSTATED | — | — | — | CAPEX | FY26 | EST | 70% |
| “Fax: +91 80 4682 3999 Registrar and Share Transfer Agents KFin Technologies Limited (Unit: Syngene International Limited) Plot No. 31 & 32, Selenium Tower - B,…” AR · +1 DOC | ||||||||
| Renewable Energy | UNSTATED | — | — | — | CAPEX | FY25 | EST | 70% |
| “Fax: +91 80 4682 3999 Registrar and Share Transfer Agents KFin Technologies Limited (Unit: Syngene International Limited) Plot No. 31 & 32, Selenium Tower - B,…” AR DOC | ||||||||
| China. | UNSTATED | — | — | — | SG&A | FY25 | EST | 70% |
| “(d) Capability and capacity additions during the year Q1 of FY25 was marked by the start of several pilot projects for pharma clients exploring outsourcing o…” AR DOC | ||||||||
| SUPPLIER | BASIS | EST ₹CR | RANGE | % COST | BUCKET | PERIOD | METHOD | CONF |
|---|---|---|---|---|---|---|---|---|
| DRREDDYDr. Reddy's Laboratories Ltd. | UNSTATED | 2,818 | 1,841–2,818 | 100.0% | — | FY25 | EST | 70% |
| “At Dr Reddy’s Laboratories, he established the Global Quality Management System and was also responsible for the quality oversight of all external suppliers wo…” AR DOC | ||||||||
| BIOCONBiocon Ltd. | UNSTATED | — | — | — | — | FY26 | EST | 75% |
| “ During the year, the Company has sold 8,000,000 equity shares of Syngene International limited in the open market.” AR · +1 DOC | ||||||||
| NHNarayana Hrudayalaya Ltd. | UNSTATED | — | — | — | R&D | FY26 | EST | 75% |
| “She also serves as the Executive Chairperson of Syngene International Limited, a contract research, development and manufacturing organization offering integra…” AR DOC | ||||||||
| AADHARHFCAadhar Housing Finance Ltd. | UNSTATED | — | — | — | — | FY25 | EST | 75% |
| “She brings with her extensive expertise in finance, governance, and risk management, and currently serves on the Boards of several reputed organisations, inclu…” AR DOC | ||||||||
| ONESOURCEOnesource Specialty Pharma Ltd. | UNSTATED | — | — | — | — | FY25 | EST | 75% |
| “As a result, the ageing for the current year is not comparable with the previous year.OneSource Specialty Pharma Limited 200 Notes forming part of the Standalo…” AR DOC | ||||||||
| Financial Year | UNSTATED | — | — | — | COGS | FY26 | EST | 75% |
| “Percentage of input material (inputs to total inputs by value) sourced from suppliers: FY25 (Current Financial Year) FY24 (Previous Financial Year) Directly so…” AR · +1 DOC | ||||||||
| BIOCONBiocon Ltd. | UNSTATED | — | — | — | R&D | FY26 | EST | 70% |
| “Syngene International Limited (Contract Research, Development & Manufacturing Organization - CRDMO): Syngene delivers integrated, end-to-end research and manuf…” AR · +1 DOC | ||||||||
| BIOCONBiocon Ltd. | UNSTATED | — | — | — | COGS | FY25 | EST | 70% |
| “ Received Voluntary Action Indicated (VAI) status from U.S. FDA for manufacturing facilities in India and Malaysia, enabling new product approvals in the U.S.…” AR DOC | ||||||||
| Business | UNSTATED | — | — | — | — | FY26 | EST | 70% |
| “Workstreams across HR, Supply Chain, and Ease of Doing Business progressed, including a shared supplier database aligned to sustainability and Scope 3 paramete…” AR DOC | ||||||||
| Financial Year | UNSTATED | — | — | — | — | FY26 | EST | 70% |
| “Benefits FY25 Current Financial Year FY24 Previous Financial Year No. of employees covered as a % of total employees No. of workers covered as a % of total wor…” AR · +1 DOC | ||||||||
| Others | UNSTATED | — | — | — | SG&A | FY26 | EST | 70% |
| “Additionally, Syngene integrates sustainability principles into its procurement processes, encouraging vendors to adopt environmentally responsible and sociall…” AR DOC | ||||||||
| China. | UNSTATED | — | — | — | — | FY25 | EST | 70% |
| “ China-independent supply chain development continued through strategic sourcing from the Indian ecosystem, and engagement with global suppliers to establish …” AR DOC | ||||||||
| China. | UNSTATED | — | — | — | R&D | FY25 | EST | 70% |
| “Research Services recorded moderate growth in FY25, driven by increased R&D externalization by large pharma and supplier diversification away from China, benef…” AR DOC | ||||||||
| SOURCE | READ | % | LAST READ |
|---|---|---|---|
| ANNOUNCEMENTS | 6/6 | 100% | 07-NOV-26 |
| ANNUAL | 4/4 | 100% | 15-OCT-26 |
| CONCALL | 4/4 | 100% | 15-OCT-26 |
| ORDERS | 6/6 | 100% | 07-NOV-26 |
| SCREENER | 1/1 | 100% | 10-NOV-26 |
| SIGNAL | VALUE | AS OF | INPUTS |
|---|---|---|---|
| CUSTOMER HHI | 0.371 | 14-NOV-26 | Britannia Industries Ltd. share 44% · Bajaj Auto Ltd. share 18% · Trent Ltd. share 38% |
| CUST MOM 1M | +2.7% | 14-NOV-26 | from 15-OCT-26 · Britannia Industries Ltd. -2.1% w 0 · Bajaj Auto Ltd. +4.5% w 0 · Biocon Ltd. +3.4% w 0 · Kfin Technologies Ltd. +6.4% w 0 · Narayana Hrudayalaya Ltd. +7.8% w 0 · Trent Ltd. +7.3% w 0 |
| SUPP MOM 1M | +13.2% | 14-NOV-26 | from 15-OCT-26 · Biocon Ltd. +3.4% w 0 · Narayana Hrudayalaya Ltd. +7.8% w 0 · Aadhar Housing Finance Ltd. -4.3% w 0 · Onesource Specialty Pharma Ltd. +12.3% w 0 · Dr. Reddy's Laboratories Ltd. +13.2% w 1 |